Bora Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Bora Pharmaceuticals has a total shareholder equity of NT$13.9B and total debt of NT$17.9B, which brings its debt-to-equity ratio to 128.3%. Its total assets and total liabilities are NT$43.6B and NT$29.6B respectively. Bora Pharmaceuticals's EBIT is NT$4.0B making its interest coverage ratio 13.1. It has cash and short-term investments of NT$6.5B.
Key information
128.3%
Debt to equity ratio
NT$17.87b
Debt
| Interest coverage ratio | 13.1x |
| Cash | NT$6.48b |
| Equity | NT$13.93b |
| Total liabilities | NT$29.64b |
| Total assets | NT$43.57b |
Recent financial health updates
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19Recent updates
Bora Pharmaceuticals' (TWSE:6472) Earnings Are Weaker Than They Seem
Nov 21Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?
Oct 04Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects
Jul 18Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?
Jun 13Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Apr 10Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality
Mar 14Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?
Mar 17Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment
Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)
Jan 27Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings
Dec 29Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?
Dec 09Financial Position Analysis
Short Term Liabilities: 6472's short term assets (NT$23.8B) exceed its short term liabilities (NT$13.1B).
Long Term Liabilities: 6472's short term assets (NT$23.8B) exceed its long term liabilities (NT$16.5B).
Debt to Equity History and Analysis
Debt Level: 6472's net debt to equity ratio (81.7%) is considered high.
Reducing Debt: 6472's debt to equity ratio has increased from 32% to 128.3% over the past 5 years.
Debt Coverage: 6472's debt is not well covered by operating cash flow (13.2%).
Interest Coverage: 6472's interest payments on its debt are well covered by EBIT (13.1x coverage).